搜尋結果
Wegovy, Mounjaro prices cut as British pharmacies compete for weight-loss patients
Reuters· 1 日前Online pharmacies and slimming clinics are cutting prices for Wegovy and Mounjaro in Britain ...
Amgen investors await weight-loss drug data
Reuters· 2 日前, opens new tab investors eyeing dramatic share price gains for rivals with successful obesity ...
Eli Lilly assures investors it can overcome the high-quality problem of too much demand
CNBC· 3 日前The numbers leave little doubt that the long-term Eli Lilly success story remains intact, as demand for its new diabetes ...
Can Ozempic Maker Novo Nordisk Keep Up Its Momentum? - What’s News - WSJ Podcasts
The Wall Street Journal· 1 日前Emily Field: This morning, Novo talked about a quadrupling of new patients starting Wegovy on a weekly basis in the United ...
Forbes Daily: Weed Stocks Light Up After DEA Reclassification
Forbes· 3 日前Home prices across the U.S. rose by 6.4% in February from the previous year, the fastest growth ...
Weight-loss drug drives Eli Lilly to raise 2024 sales forecast by $2 billion
Reuters· 3 日前, opens new tab weight-loss drug Zepbound drove the company to raise its annual sales forecast ...
Repeated Reimbursement Haircuts From CMS Won’t Bend The Cost Curve
Forbes· 2 日前In the fury of the healthcare debates over the last decade, most people have come to realize ...
Wegovy Sales More Than Double as Demand Soars
The Wall Street Journal· 1 日前Novo Nordisk raised its full-year guidance to reflect better pricing in the U.S. and as global ...
Ozempic Maker Novo Nordisk Beats Profit Forecasts Amid Weight Loss Drug Frenzy
Forbes· 2 日前Danish pharma giant Novo Nordisk raised its 2024 outlook and beat profit expectations in its first-quarter earnings Thursday ...
Morning Bid: Fed QT taper calms the horses, yen pops again
Reuters· 1 日前Anxious bond traders seem to have taken solace from the Federal Reserve's surprisingly ...